Experimental Parkinson’s Drug Solengepras Reduces ‘Off-Time’ in Study

Cerevance's Parkinson's drug solengepras reduces off-time in late-stage trial

Cerevance's experimental pill solengepras helped Parkinson's disease patients control symptoms for longer periods each day in a successful late-stage clinical trial, potentially offering a new treatment option.